A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian

Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and...

Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.

Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.

News | Contrast Media | September 12, 2018

In February 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Maryland, to explore...

cardiologist Ted Feldman, M.D., at TCT 2017.
Feature | TCT | September 12, 2018

September 12, 2018 – The Cardiovascular Research Foundation (CRF) has announced the 15 late-breaking trials and 12...

Antithrombin Drug Ineffective in Heart Failure With Sinus Rhythm and Coronary Disease
News | Heart Failure | September 07, 2018

September 7, 2018 — The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival,...

Thrombolytic Science Initiates Phase 2 Trial of Novel Ischemic Stroke Treatment Regimen
News | Antiplatelet and Anticoagulation Therapies | September 07, 2018

September 7, 2018 — A new Phase 2 clinical trial looks to confirm the efficacy and safety of Thrombolytic Science...

Tafamidis Improves Survival in Rare Heart Condition
News | Heart Failure | September 06, 2018

September 6, 2018 — Tafamidis is the first treatment to improve survival and reduce hospitalizations in a rare heart...

Bilateral Artery Use Does Not Improve 10-Year CABG Outcomes
News | Cardiovascular Surgery | September 06, 2018

September 6, 2018 — While it is firmly established that the use of one internal thoracic artery can improve life...

Gore Acquires Pipeline Medical Technologies Inc.
News | Heart Valve Technology | September 06, 2018

September 6, 2018 – W. L. Gore & Associates Inc. (Gore) announced the acquisition of Pipeline Medical...

Key Patient Preparations for a CT Scan
News | Computed Tomography (CT) | September 05, 2018

September 5, 2018 — The Center for Diagnostic Imaging (CDI) in Miami recently released a list of important...

Figure 1: Segmentation performed on the left atrium, left ventricle and mitral bioprosthesis. Landmarks are placed on the site of optimal transseptal access into the left atrium and the mitral PVL.

Figure 1: Segmentation performed on the left atrium, left ventricle and mitral bioprosthesis. Landmarks are placed on the site of optimal transseptal access into the left atrium and the mitral PVL.

Sponsored Content | Case Study | Ultrasound Transesophageal echo (TEE) | September 05, 2018 | Cyril Danielkutty B.E., Dillon Weiss, B.S., Chad A Kliger, M.D., M.S.

Transcatheter interventions have become a mainstay in cardiac care as treatments for structural and congenital heart...

The Fysicon QMAPP hemodynamic monitoring system is the newest system to gain FDA clearance. It is about the size of a ream of paper.

The Fysicon QMAPP hemodynamic monitoring system is the newest system to gain FDA clearance. It is about the size of a ream of paper.

Feature | Hemodynamic Monitoring Systems | September 05, 2018 | Dave Fornell, Editor

Beyond measuring blood flow, pressure, oxygen levels and other vital signs in the cardiac catheterization lab,...

SCAI and the European Society of Cardiology recently added iFR to their guidelines.

An illustration of Philip’s iFR technology, showing the iFR pressure readings and a fusion angio image indicating pressure drops in the vessel during wire pull back. SCAI and the European Society of Cardiology recently added iFR to their guidelines.

Feature | FFR Technologies | September 05, 2018 | Dave Fornell, Editor

The use of invasive, pressure wire-based fractional flow reserve (FFR) in the cath lab is now considered the gold...

Biotronik Named Exclusive U.S. Distributor of MoMe Kardia Diagnostic Monitor
News | Remote Monitoring | September 05, 2018

September 5, 2018 — Biotronik announced it is now the exclusive U.S. distributor for the MoMe Kardia external...

Overlay Init